Opioid Reformulation for Abuse Deterrence - Filed as a CMC Supplement in Less Than a Year

Article

Sponsored Content

It is no secret that Opioid abuse is an ongoing public health emergency. Societal™’s client stood at an impasse in pursuit of providing pain relief to patients, while following the recommendation of the FDA to reformulate the product for abuse deterrence.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Content
Site Logo

Innovations in Pregastric Absorption Drug Delivery & Orally Disintegrating Tablets

Catalent
July 16th 2025
Article
Site Logo

Rethinking Inhalation Drug Development

Experic
July 15th 2025
Article

What it takes to bring complex inhaled therapies to market—faster and smarter.

Site Logo

CDMO Solutions – Reducing Risk and Accelerating Time to Market

Experic
July 15th 2025
Article

Discover how our precision processes and dedicated personal support can expedite even the most complex drug programs.

Site Logo

Unparalleled Expertise and Transparency Drive a Unique Development, Manufacturing, and Clinical Supply Experience

Experic
July 15th 2025
Article

Step into a model designed for adaptability, speed, and success in specialized drug development.

Site Logo

Streamlined Product Development Leveraging Pharmaceutical Classification Models

Serán
July 11th 2025
Article
Site Logo

Selecting container closure components with confidence: A data-driven approach to container closure integrity

West Pharmaceutical Services
June 13th 2025
Article

Drug products in development require compatible packaging to meet milestones and gain approval. West supports pharmaceutical partners with a data-driven process to give you confidence with closure containment that meets requirements in the modern regulatory landscape.